Drug lookup
Drug reference

Desflurane

General Anesthetic · Anaesthesia

Also known as Desflurane volatile liquid

General AnestheticAnaesthesia
CDSCO approved
EXCRETION
not curated
INTERACTIONS
9 major
SEVERE in our sources
PREGNANCY
May depress neonatal respiration if used during delivery.
FDA category + note
Top interactionssee all 10
  • Desiccated Co2 AbsorbentSevereTextbookG&G 14e · p479
  • DroperidolSevereDatabaseDDInter
  • EpinephrineSevereDatabaseDDInter
  • IsocarboxazidSevereDatabaseDDInter

Mechanism

Desflurane is a fluorinated methyl ethyl ether volatile anesthetic that potentiates GABA-A receptor-mediated inhibitory neurotransmission and inhibits NMDA receptor-mediated excitatory transmission. Its very low blood:gas partition coefficient (0.42) — the lowest of the volatile anesthetics — enables the most rapid induction and emergence from anesthesia. However, its pungency and airway irritation preclude use for inhalational induction, and it requires a heated pressurized vaporizer due to its near-room-temperature boiling point (22.8°C).

Indications

Induction of anaesthesia (but not recommended)Maintenance of anaesthesia (in nitrous oxide–oxygen)Maintenance of anaesthesia in caesarean section (in nitrous oxide–oxygen)maintenance of anesthesia (after intravenous induction)

Dosing

Adult
Induction: Initially 0.5 %, increased to 3 %, adjusted according to response, administered using specifically calibrated vaporiser. Maintenance (in nitrous oxide–oxygen): 1–2.5 %, administered using specifically calibrated vaporiser; an additional 0.5–1% may be required when given with oxygen alone.…

Pharmacokinetics

Excretion
minimally metabolized; more than 99% eliminated unchanged through the lungs

Contraindications

  • Hepatotoxicity in those sensitised to halogenated anaesthetics
  • primary anesthetic for induction (due to irritant properties)
  • use with desiccated CO2 absorbents (risk of carbon monoxide production)

Side effects

Common
carboxyhaemoglobinaemiachest discomfortcognitive impairmentdeliriumdyspnoeaileusmood altered (that can last several days)myoglobinuriaskin reactionshypotensionCNS depressant effectsmyalgiairritates the tracheobronchial tree (coughing, salivation, bronchospasm)transient tachycardia and hypertension (with abrupt increases in concentration due to sympathetic stimulation)concentration-dependent increase in respiratory rate and decrease in tidal volumestrong airway irritant (coughing, breath-holding, laryngospasm, excessive respiratory secretions)hypotension (primarily by decreasing systemic vascular resistance)skeletal muscle relaxation
Serious
  • haemorrhage
  • hepatic disorders
  • hyperkalaemia
  • malignant hyperthermia
  • QT interval prolongation
  • rhabdomyolysis
  • seizure
  • hepatotoxicity (in sensitised individuals)
  • myocardial infarction
  • myocardial ischaemia
  • abdominal pain
  • asthenia
  • heart failure
  • hypokalaemia
  • malaise
  • metabolic acidosis
  • pancreatitis acute
  • shock
  • ventricular dysfunction
  • visual acuity decreased
  • can increase ICP in patients with poor intracranial compliance
  • carbon monoxide production (with desiccated CO2 absorbents)

Pregnancy & lactation

Pregnancy

May depress neonatal respiration if used during delivery.

Lactation

Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.

Drug interactions

Desiccated Co2 Absorbent
Severe
Textbook

Carbon monoxide production.

The interaction can be prevented by the use of well-hydrated, fresh CO2 absorbent.

Source: G&G 14e · p479

Droperidol
Severe
Database

Clinical effect not specified

Source: DDInter

Epinephrine
Severe
Database

Clinical effect not specified

Source: DDInter

Isocarboxazid
Severe
Database

Clinical effect not specified

Source: DDInter

Norepinephrine
Severe
Database

Clinical effect not specified

Source: DDInter

Phenelzine
Severe
Database

Clinical effect not specified

Source: DDInter

Selegiline
Severe
Database

Clinical effect not specified

Source: DDInter

Sodium Oxybate
Severe
Database

Clinical effect not specified

Source: DDInter

Tranylcypromine
Severe
Database

Clinical effect not specified

Source: DDInter

Competitive Blockers
Moderate
Textbook

Increased neuromuscular blockade from competitive blockers.

Source: KDT 7e · p347-359

2 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other General Anesthetic drugs

Ask House about Desflurane

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Katzung·Verified: 2026-05-13 · House clinical team